GLUD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.406200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.788850E-01
Normal-vs-Stage2
4.477200E-01
Normal-vs-Stage3
8.365200E-01
Normal-vs-Stage4
2.507600E-01
Stage1-vs-Stage2
5.850200E-01
Stage1-vs-Stage3
1.668590E-01
Stage1-vs-Stage4
9.225000E-01
Stage2-vs-Stage3
2.641400E-01
Stage2-vs-Stage4
5.845000E-01
Stage3-vs-Stage4
2.410200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.665200E-01
Normal-vs-AfricanAmerican
3.862800E-01
Normal-vs-Asian
3.521800E-01
Caucasian-vs-AfricanAmerican
6.957400E-01
Caucasian-vs-Asian
5.399200E-01
AfricanAmerican-vs-Asian
4.748200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.306000E-01
Normal-vs-Female
4.593400E-01
Male-vs-Female
3.188000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.707600E-01
Normal-vs-Age(41-60Yrs)
2.585800E-01
Normal-vs-Age(61-80Yrs)
6.078800E-01
Normal-vs-Age(81-100Yrs)
1.787020E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.774600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.485800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.963200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.675600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.754600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.656040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.373800E-01
Normal-vs-Daily Drinker
4.478800E-01
Normal-vs-Weekly Drinker
7.529800E-01
Normal-vs-Occasional Drinker
1.857830E-01
Normal-vs-Social Drinker
7.046800E-01
Non Drinker-vs-Daily Drinker
3.016800E-01
Non Drinker-vs-Weekly Drinker
6.683000E-01
Non Drinker-vs-Occasional Drinker
2.533900E-02
Non Drinker-vs-Social Drinker
6.929800E-01
Daily Drinker-vs-Weekly Drinker
1.917400E-01
Daily Drinker-vs-Occasional Drinker
3.172200E-01
Daily Drinker-vs-Social Drinker
1.902780E-01
Weekly Drinker-vs-Occasional Drinker
2.768100E-02
Weekly Drinker-vs-Social Drinker
9.549200E-01
Occasional Drinker-vs-Social Drinker
1.858460E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.192420E-01
Normal-vs-Grade 2
2.586400E-02
Normal-vs-Grade 3
1.044190E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.958500E-02
Grade 1-vs-Grade 3
5.740000E-03
Grade 1-vs-Grade 4
1.192420E-01
Grade 2-vs-Grade 3
2.516400E-01
Grade 2-vs-Grade 4
2.586400E-02
Grade 3-vs-Grade 4
1.044190E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.974000E-01
Normal-vs-NonDiabetic
4.744400E-01
Diabetic-vs-NonDiabetic
9.692400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.071580E-01
Normal-vs-NoPancreatitis
4.835800E-01
Pancreatitis-vs-NoPancreatitis
3.614200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.211200E-01
Normal-vs-N1
4.696400E-01
N0-vs-N1
9.432400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.619630E-01
Normal-vs-TP53-NonMutant
8.008200E-01
TP53-Mutant-vs-TP53-NonMutant
2.396500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
